Adult ARV Guidelines

  • 2018 Recommendations, Saag MS, Benson CA, Gandhi RT, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA Panel. JAMA. 2018;320(4):379-396. (PMID: 30043070)
  • 2016 Recommendations, Günthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society-USA Panel. JAMA. 2016.;316(2):191-210. (PMID:27404187)
  • 2014 Recommendations, Günthard HG, Aberg JA, Eron JJ, et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA panel. JAMA. 2014 Jul 23-30;312(4):410-425. (PMID: 25038359)
  • 2012 Recommendations, Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4):387-402. (PMID: 22820792)
  • 2010 Recommendations, Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International Antiviral Society-USA panel. JAMA. 2010 Jul 21;304(3):321-33. (PMID: 20639566.)
  • 2008 Recommendations, Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008 Aug 6;300(5):555-70. (PMID: 18677028)
  • 2006 Recommendations, Hammer SM, Saag MS, Schechter M, et al. Antiretroviral treatment of adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006 Aug 16;296(7):827-43. (PMID: 18677028)
  • 2004 Recommendations, Yeni PG, Hammer SM, Hirsch MS, et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International AIDS Society-USA panel. JAMA. 2004 Jul 14;292(2):251-65. (PMID: 15249575)
  • 2002 Recommendations, Yeni PG, Hammer SM, Carpenter CC, et al. Antiretroviral treatment of adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA panel. JAMA. 2002 Jul 10;288(2):222-35. (PMID: 12095387)
  • 2000 Recommendations, Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA panel. JAMA. 2000 Jan 19;283(3):381-90. Review. (PMID: 10647802)
  • 1998 Recommendations, Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA panel. JAMA. 1998 Jul 1;280(1):78-86. Review. (PMID: 9660368)
  • 1997 Recommendations, Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA panel. JAMA. 1997 Jun 25;277(24):1962-9. (PMID: 9200638)
  • 1996 Recommendations, Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA. 1996 Jul 10;276(2):146-54. Review. (PMID: 8656507)

Resistance Testing Recommendations

  • 2018 Recommendations, Günthard HF, Calvez V, Paredes R, et al. Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society-USA panel. Clin Infect Dis. 2019;68(2):177-187. (PMID: 30052811)
  • 2008 Recommendations, Hirsch MS, Günthard HF, Schapiro JM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008;47(2):266-285. (PMID: 18549313)
  • 2003 Recommendations, Hirsch MS, Brun-Vézinet F, Clotet B, et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2003;37(1):113–28. (PMID: 12830416)
  • 2000 Recommendations, Hirsch MS, Brun-Vézinet F, D’Aquila RT, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA panel. JAMA. 2000;283(18):2417-2426. (PMID: 10815085)
  • 1998 Recommendations, Hirsch MS, Conway B, D’Aquila RT, et al. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. JAMA. 2000;279(24):1984-1991. (PMID: 9643863)

HIV Prevention

  • 2014 Recommendations, Marrazzo JM, del Rio C, Holtgrave DR, et al. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA panel. JAMA. 2014;31(3):257-75. (PMID: 25038358)

Management of Metabolic Complications Recommendations

  • 2002 Recommendations, Schambelan M, Benson CA, Carr A, et al. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an IAS-USA panel. J Acquir Immune Defic Syndr. 2014;312(4):390-409.